Literature DB >> 34011298

Two-stage prediction model for in-hospital mortality of patients with influenza infection.

Chan-Wa Cheong1, Chien-Lin Chen1,2, Chih-Huang Li1, Chen-June Seak1,2, Hsiao-Jung Tseng3, Kuang-Hung Hsu1,4, Chip-Jin Ng1, Cheng-Yu Chien5,6,7.   

Abstract

BACKGROUND: Infleunza is a challenging issue in public health. The mortality and morbidity associated with epidemic and pandemic influenza puts a heavy burden on health care system. Most patients with influenza can be treated on an outpatient basis but some required critical care. It is crucial for frontline physicians to stratify influenza patients by level of risk. Therefore, this study aimed to create a prediction model for critical care and in-hospital mortality.
METHODS: This retrospective cohort study extracted data from the Chang Gung Research Database. This study included the patients who were diagnosed with influenza between 2010 and 2016. The primary outcome of this study was critical illness. The secondary analysis was to predict in-hospital mortality. A two-stage-modeling method was developed to predict hospital mortality. We constructed a multiple logistic regression model to predict the outcome of critical illness in the first stage, then S1 score were calculated. In the second stage, we used the S1 score and other data to construct a backward multiple logistic regression model. The area under the receiver operating curve was used to assess the predictive value of the model.
RESULTS: In the present study, 1680 patients met the inclusion criteria. The overall ICU admission and in-hospital mortality was 10.36% (174 patients) and 4.29% (72 patients), respectively. In stage I analysis, hypothermia (OR = 1.92), tachypnea (OR = 4.94), lower systolic blood pressure (OR = 2.35), diabetes mellitus (OR = 1.87), leukocytosis (OR = 2.22), leukopenia (OR = 2.70), and a high percentage of segmented neutrophils (OR = 2.10) were associated with ICU admission. Bandemia had the highest odds ratio in the Stage I model (OR = 5.43). In stage II analysis, C-reactive protein (OR = 1.01), blood urea nitrogen (OR = 1.02) and stage I model's S1 score were assocaited with in-hospital mortality. The area under the curve for the stage I and II model was 0.889 and 0.766, respectively.
CONCLUSIONS: The two-stage model is a efficient risk-stratification tool for predicting critical illness and mortailty. The model may be an optional tool other than qSOFA and SIRS criteria.

Entities:  

Year:  2021        PMID: 34011298     DOI: 10.1186/s12879-021-06169-6

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  20 in total

Review 1.  Pandemic influenza: a never-ending story.

Authors:  Seiji Kageyama
Journal:  Yonago Acta Med       Date:  2011-09-01       Impact factor: 1.641

2.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

Review 3.  Socioeconomic impact of seasonal (epidemic) influenza and the role of over-the-counter medicines.

Authors:  Michael E Klepser
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

4.  Prognostic accuracy of SIRS criteria and qSOFA score for in-hospital mortality among influenza patients in the emergency department.

Authors:  Sheng-En Chu; Chen-June Seak; Tse-Hsuan Su; Chung-Hsien Chaou; Hsiao-Jung Tseng; Chih-Huang Li
Journal:  BMC Infect Dis       Date:  2020-05-29       Impact factor: 3.090

5.  Can the emergency department triage category and clinical presentation predict hospitalization of H1N1 patients?

Authors:  Mohammed Alshahrani; Aisha Alsubaie; Alaa Alshamsy; Bayader Alkhliwi; Hind Alshammari; Maha Alshammari; Nosibah Telmesani; Reem Alshammari; Laila Perlas Asonto
Journal:  Open Access Emerg Med       Date:  2019-09-17

Review 6.  Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.

Authors:  Sheena G Sullivan; Olivia H Price; Annette K Regan
Journal:  Ther Adv Vaccines Immunother       Date:  2019-02-07

Review 7.  Influenza virus-related critical illness: pathophysiology and epidemiology.

Authors:  Andre C Kalil; Paul G Thomas
Journal:  Crit Care       Date:  2019-07-19       Impact factor: 9.097

8.  Health and economic burden of influenza-associated illness in South Africa, 2013-2015.

Authors:  Stefano Tempia; Jocelyn Moyes; Adam L Cohen; Sibongile Walaza; Ijeoma Edoka; Meredith L McMorrow; Florette K Treurnicht; Orienka Hellferscee; Nicole Wolter; Anne von Gottberg; Athermon Nguweneza; Johanna M McAnerney; Halima Dawood; Ebrahim Variava; Cheryl Cohen
Journal:  Influenza Other Respir Viruses       Date:  2019-06-11       Impact factor: 4.380

9.  Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.

Authors:  Lone Simonsen; Peter Spreeuwenberg; Roger Lustig; Robert J Taylor; Douglas M Fleming; Madelon Kroneman; Maria D Van Kerkhove; Anthony W Mounts; W John Paget
Journal:  PLoS Med       Date:  2013-11-26       Impact factor: 11.069

10.  Severe influenza treatment guideline.

Authors:  Won Suk Choi; Ji Hyeon Baek; Yu Bin Seo; Sae Yoon Kee; Hye Won Jeong; Hee Young Lee; Byung Wook Eun; Eun Ju Choo; Jacob Lee; Young Keun Kim; Joon Young Song; Seong-Heon Wie; Jin Soo Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.